ERBB2 and neoplasm: To explore the mechanism underlying the difference in trastuzumab anti-tumor efficacy between the two HER-2 IHC 3+ and FISH AMP PDGAX models (PDGAX005 and PDGAX001), molecular genetic studies were performed.